Risk factors of oropharyngeal carriage of Pseudomonas aeruginosa among patients from a Medical-Surgical Intensive Care Unit

Brazilian Journal of Infectious Diseases

Volumn 13, Issue 3, 2009, Pages 173-176

  Fortaleza, Carlos Magno Castelo Branco ^a   Figueiredo, Lígia Castellon ^a   Beraldo, Carolina Contador ^b   De Melo, Edson Carvalho ^a,b   Póla, Patrícia Maria Sales ^b   Aragão, Valéria Drummond Nagem ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Bauru State Hospital   (Brazil)

Author keywords

Colonization; Intensive care unit; Oropharyngeal carriage; Pseudomonas aeruginosa; Surveillance cultures

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; IMMUNOSUPPRESSIVE AGENT; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE CONTROL STUDY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DEVICE; FEMALE; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; MALE; MULTIDRUG RESISTANCE; NASOGASTRIC TUBE; NONHUMAN; OROPHARYNX; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOLID TUMOR; STEROID THERAPY; SURGICAL PATIENT; URINARY CATHETER;

ANTI-BACTERIAL AGENTS; CARRIER STATE; COHORT STUDIES; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OROPHARYNX; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77749301569     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000300004     Document Type: Article

References (16)

1. Garrouste-Orgeas M., Chevert S., Arlet G. et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult Intensive Care Unit patients. Am J Respir Crit Care Med 1997;156:1647-55.
2. Limeback H. Implications of oral infections on systemic diseases in the institutionalized elderly with a special focus on pneumonia. Ann Periodontol 1998;3:262-75.
3. Morrison, Jr. A.J., Wenzel R.P. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984;6(Suppl 3):S627-S42.
4. Murthy S.K., Baltch A.L., Smith R.P. et al. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients. J Clin Microbiol 1989;27:35-40.
5. Leibovitz A., Dan M., Zinger J. et al. Pseudomonas aeruginosa and the oropharyngeal ecosystem of tube-fed patients. Emerg Infect Dis 2003,9:956-9.
6. Bonten M.J.M., Bergmans D.C.J.J., Speijer H., Strobbering E.E. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in Intensive Care Units. Am J Respir Crit Care Med 1999,160:1212-9.
7. Ortega B., Groenvald J., Schultsz C. Endemic multidrug-resistant Pseudomonas aeruginosa in critically ill patients. Infect Control Hosp Epidemiol 2004,25:825-31.
8. th ed. Pennsylvania: CLSI; 2003.
9. World Health Organization. International Classification of Diseases. tenth revision, 2005 update. Geneva, Switzerland: WHO; 2005.
10. Knaus W.A., Draper E.A., Wagner D.R., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
11. Fillius P.M.G., Gyssens I.C., Kershof I.M. et al. Colonization and resistance dynamics of Gram-negative bacteria in patients during and after hospitalization. Antimicrob Agents Chemother 2005;49:2879-86.
12. Berthelot P., Grattard F., Mahul P. et al. Prospective study of nosocomial colonization and infection due to Pseudomonas aeruginosa in mechanically ventilated patients. Intensive Care Med 2001;27:503-12.
13. Asboe D., Gant V., Aucken H.M. et al. Persistance of Pseudomonas aeruginosa strains in respiratory infection in AIDS patients. AIDS 1998;12:1771-5.
14. Sorvillo F., Beall G., Turner P.A. et al. Incidence and determinants of Pseudomonas aeruginosa infection among persons with HIV: association with hospital exposure. Am J Infect Control 2001;29:79-84.
15. Bonfiglio G. Is Levofloxacin as active as Ciprofloxacin against Pseudomonas aeruginosa? Chemotherapy 2001;47:239-42.
16. Harris A.D., Carmeli Y., Samore M.H. et al. Impact of severity of illness bias and control group misclassification bias in casecontrol studies of antimicrobial resistant organisms. Infect Control Hosp Epidemiol 2005;26:342-5.